These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 19876898)

  • 21. A novel mutation in the HEXA gene specific to Tay-Sachs disease carriers of Jewish Iraqi origin.
    Karpati M; Peleg L; Gazit E; Akstein E; Goldman B
    Clin Genet; 2000 May; 57(5):398-400. PubMed ID: 10852376
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tay-Sachs disease carrier screening: a 21-year experience.
    D'Souza G; McCann CL; Hedrick J; Fairley C; Nagel HL; Kushner JD; Kessel R
    Genet Test; 2000; 4(3):257-63. PubMed ID: 11142756
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tay-Sachs disease--carrier screening, prenatal diagnosis, and the molecular era. An international perspective, 1970 to 1993. The International TSD Data Collection Network.
    Kaback M; Lim-Steele J; Dabholkar D; Brown D; Levy N; Zeiger K
    JAMA; 1993 Nov; 270(19):2307-15. PubMed ID: 8230592
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tay-Sachs disease screening and diagnosis: evolving technologies.
    Hechtman P; Kaplan F
    DNA Cell Biol; 1993 Oct; 12(8):651-65. PubMed ID: 8397824
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The major defect in Ashkenazi Jews with Tay-Sachs disease is an insertion in the gene for the alpha-chain of beta-hexosaminidase.
    Myerowitz R; Costigan FC
    J Biol Chem; 1988 Dec; 263(35):18587-9. PubMed ID: 2848800
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tay-Sachs disease and HEXA mutations among Moroccan Jews.
    Kaufman M; Grinshpun-Cohen J; Karpati M; Peleg L; Goldman B; Akstein E; Adam A; Navon R
    Hum Mutat; 1997; 10(4):295-300. PubMed ID: 9338583
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tay-Sachs disease carrier screening: a model for prevention of genetic disease.
    Kaplan F
    Genet Test; 1998; 2(4):271-92. PubMed ID: 10464605
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A gel electrophoretic assay for detecting the insertion defect in Ashkenazi Jewish carriers of Tay-Sachs disease.
    Shore S; Myerowitz R
    Anal Biochem; 1990 Apr; 186(1):179-81. PubMed ID: 2356966
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Platelet hexosaminidase a enzyme assay effectively detects carriers missed by targeted DNA mutation analysis.
    Nakagawa S; Zhan J; Sun W; Ferreira JC; Keiles S; Hambuch T; Kammesheidt A; Mark BL; Schneider A; Gross S; Schreiber-Agus N
    JIMD Rep; 2012; 6():1-6. PubMed ID: 23430931
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ashkenazi Jewish population screening for Tay-Sachs disease: the international and Australian experience.
    Lew RM; Burnett L; Proos AL; Barlow-Stewart K; Delatycki MB; Bankier A; Aizenberg H; Field MJ; Berman Y; Fleischer R; Fietz M
    J Paediatr Child Health; 2015 Mar; 51(3):271-9. PubMed ID: 24923490
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prenatal Diagnosis of Tay-Sachs Disease.
    Zhang J; Chen H; Kornreich R; Yu C
    Methods Mol Biol; 2019; 1885():233-250. PubMed ID: 30506202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tay-Sachs disease: a pilot screening program for the detection of the heterozygote in the Charleston Jewish community.
    Rogers JF; Hogan EL; Jorgenson RJ
    South Med J; 1976 Nov; 69(11):1453-5. PubMed ID: 1019641
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A mutation common in non-Jewish Tay-Sachs disease: frequency and RNA studies.
    Akerman BR; Zielenski J; Triggs-Raine BL; Prence EM; Natowicz MR; Lim-Steele JS; Kaback MM; Mules EH; Thomas GH; Clarke JT
    Hum Mutat; 1992; 1(4):303-9. PubMed ID: 1301938
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sandhoff disease heterozygote detection: a component of population screening for Tay-Sachs disease carriers. I. Statistical methods.
    Cantor RM; Lim JS; Roy C; Kaback MM
    Am J Hum Genet; 1985 Sep; 37(5):912-21. PubMed ID: 4050790
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Beta-hexosaminidase: biosynthesis and processing of the normal enzyme, and identification of mutations causing Jewish Tay-Sachs disease.
    Mahuran DJ
    Clin Biochem; 1995 Apr; 28(2):101-6. PubMed ID: 7628066
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tay-Sachs disease heterozygote detection in Brazil: comparison between tears and leukocytes as beta-hexosaminidase A source.
    Buchalter MS; Wannmacher CM; Wajner M
    J Inherit Metab Dis; 1984; 7(1):35-7. PubMed ID: 6234430
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tandem mass spectrometric enzyme assay for simultaneous detection of Tay-Sachs and Sandhoff diseases in dried blood spots for newborn screening.
    Herbst ZM; Hold S; Gelb MH; Khaledi H
    Mol Genet Metab; 2024 Aug; 142(4):108517. PubMed ID: 38908075
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An unusual genotype in an Ashkenazi Jewish patient with Tay-Sachs disease.
    Shore S; Tomczak J; Grebner EE; Myerowitz R
    Hum Mutat; 1992; 1(6):486-90. PubMed ID: 1301958
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Specific mutations in the HEXA gene among Iraqi Jewish Tay-Sachs disease carriers: dating of founder ancestor.
    Karpati M; Gazit E; Goldman B; Frisch A; Colombo R; Peleg L
    Neurogenetics; 2004 Feb; 5(1):35-40. PubMed ID: 14648242
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Tay-Sachs disease gene in North American Jewish populations: geographic variations and origin.
    Petersen GM; Rotter JI; Cantor RM; Field LL; Greenwald S; Lim JS; Roy C; Schoenfeld V; Lowden JA; Kaback MM
    Am J Hum Genet; 1983 Nov; 35(6):1258-69. PubMed ID: 6650504
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.